RSSBiotech Stocks

Fortress Biotech: A Unique Company Aiming To Make A Big Impact In Medicine

Fortress Biotech: A Unique Company Aiming To Make A Big Impact In Medicine

| October 11, 2018 | 0 Comments

Note: This is a review of Fortress Biotech as a company. Do your own research before making any investment decisions. The biopharmaceutical industry is at the forefront of developing the healthcare solutions of tomorrow. One interesting company, Fortress Biotech (FBIO), has taken a unique and different approach to drug discovery and drug development. Fortress Biotech’s business model […]

Continue Reading

7 Cheap Biotech Stocks To Buy Now

7 Cheap Biotech Stocks To Buy Now

These biotech stocks are set for a strong comeback as investors walk away from large-cap tech companies U.S equities largely treaded water on Wednesday as Wall Street reacted to legal events and President Trump’s somewhat muted reaction to them. Elsewhere, strong earnings out of the retail sector are helping boost sentiment. The release of the […]

Continue Reading

5 Clinical-Stage Biotech Stocks To Buy Under $10

5 Clinical-Stage Biotech Stocks To Buy Under $10

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk Not many sectors offer the potential for big time gains like biotech. Especially when you’re looking at smaller clinical-stage names. After all, the thrill of getting a big-time approval or even making through to the next round of FDA trial […]

Continue Reading

5 Big Biotech Stocks To Buy Under $10

5 Big Biotech Stocks To Buy Under $10

Small biotech stocks can pack a wallop For investors, biotech stocks remain one of the most dynamic sectors out there. On one hand, you have some of the largest pharmaceutical firms on the planet with multi-billion-dollar blockbuster drugs filling their coffers. On the other, you have the more stereotypical “lotto ticket” biotech stocks of clinical […]

Continue Reading

4 Triple-Digit Winners In Biotech

4 Triple-Digit Winners In Biotech

| April 25, 2017 | 0 Comments

With important catalysts coming up in 2017, these stocks could soon become triple-digit winners in your portfolio. Start building a well-diversified biotech portfolio with these four stocks.  The overall biotech sector continues to be locked in a tight trading range, especially for such a high beta sector of the market. First quarter earnings reports for […]

Continue Reading

3 Undervalued Stocks On The Verge Of A Breakout

3 Undervalued Stocks On The Verge Of A Breakout

| April 6, 2017 | 1 Comment

Buying shares at these prices might look like a gift in six month’s time. With multiple catalysts to fuel share price growth on the horizon and a lot of good news not yet baked into the share price, now is a great time to get in.  The fairy tale story for biotech investors is buying […]

Continue Reading

3 Small Biotech Moonshots To Add To Your Portfolio

3 Small Biotech Moonshots To Add To Your Portfolio

| March 16, 2017 | 0 Comments

As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio.  Sentiment on the biotech sector early in 2017 sure has […]

Continue Reading

3 Biotech Stock Beneficiaries Of A Streamlined FDA

3 Biotech Stock Beneficiaries Of A Streamlined FDA

| March 9, 2017 | 0 Comments

With lower approval wait times and decreased regulations on the horizon, long-term investing opportunities in the biotech sector haven’t looked this great in over two years. Take a look at these three stocks in particular as they will reap the most reward from a streamlined FDA.  After an approximate gain of 10% in February, the […]

Continue Reading

3 Attractive Growth Stocks With Near-Term Catalysts

3 Attractive Growth Stocks With Near-Term Catalysts

| February 16, 2017 | 0 Comments

The market is off to a much stronger start this year than the bloodbath equities were greeted with to begin 2016. Biotech, after a dismal 18 months of underperformance is no exception. Sentiment on this beaten down part of the market started to improve immediately after the unexpected election result in November. The specter of […]

Continue Reading

The 3 Golden Rules Of Successful Biotech Investing

The 3 Golden Rules Of Successful Biotech Investing

| January 19, 2017 | 0 Comments

If you want to invest successfully in one of the few sectors where 1,000% gains are anything but unusual, follow these three “golden rules” that Bret Jensen has developed over his decades-long career. The 45th President of the United States will be inaugurated this week and the stock market has started out 2017 on much […]

Continue Reading

3 Stocks Under $10 With Breakout Potential

3 Stocks Under $10 With Breakout Potential

| January 12, 2017 | 1 Comment

After executing perfectly on their business plans in 2016, these three stocks look set to reap the profits in 2017. With buyout potential and higher share prices expected in the New Year, adding these three stocks to your portfolio today looks like a smart move.  It is hard to believe 2016 has already come and […]

Continue Reading